Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
The weight-loss-drug manufacturer failed to excite investors hoping for a turnaround.
Markets
Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
World desk, Times News (2026-09-21): Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030 The weight-loss-drug manufacturer failed to excite investors hoping for a… Fuente primaria: original en MarketWatch (marketwatch.com).